Dolutegravir Aluminum and magnesium hydroxide antacid 122

Interaction Color Code
Clinical Bottom Line
Do not coadminister: Reduced levels of dolutegravir
Drug 1
Drug 1 dose
50 mg single dose
Drug 1 effect

Cmax decreased 72%, AUC decreased 74%, Cmin decreased 74%

Drug 2 dose
Maalox given simultaneously as dolutegravir
Drug 2 effect

Not studied

Clinical Effects

Potential decrease in antiretroviral efficacy

Management

Administer dolutegravir 2 hours before or 6 hours after antacids.

Import ID
122